Valtoco 15 mg (two 7.5 mg nasal spray devices) Images
Generic Name: diazepam
This medication has been identified as Valtoco 15 mg (two 7.5 mg nasal spray devices). It is supplied by Neurelis, Inc.
Valtoco is used in the treatment of Seizures and belongs to the drug class benzodiazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Valtoco 15 mg (two 7.5 mg nasal spray devices) is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images of medication


Valtoco
- Generic Name
- diazepam
- Strength
- 15 mg (two 7.5 mg nasal spray devices)
- Availability
- Prescription only
- Drug Class
- Benzodiazepine anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Neurelis, Inc.
- National Drug Code (NDC)
- 72252-0515
More about Valtoco (diazepam)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: benzodiazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Valium, Diazepam Intensol, Diastat, Diastat AcuDial, ... +3 more
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.